Signaturefd LLC grew its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 20.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,286 shares of the company’s stock after purchasing an additional 222 shares during the quarter. Signaturefd LLC’s holdings in HealthEquity were worth $135,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also modified their holdings of the business. Public Employees Retirement System of Ohio raised its holdings in HealthEquity by 0.8% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 93,547 shares of the company’s stock worth $9,800,000 after acquiring an additional 733 shares during the period. Sheets Smith Wealth Management increased its holdings in shares of HealthEquity by 1.9% during the 2nd quarter. Sheets Smith Wealth Management now owns 8,419 shares of the company’s stock worth $882,000 after purchasing an additional 157 shares during the period. Covea Finance increased its holdings in shares of HealthEquity by 22.5% during the 2nd quarter. Covea Finance now owns 39,200 shares of the company’s stock worth $4,107,000 after purchasing an additional 7,200 shares during the period. GAMMA Investing LLC increased its holdings in shares of HealthEquity by 27.7% during the 2nd quarter. GAMMA Investing LLC now owns 2,006 shares of the company’s stock worth $210,000 after purchasing an additional 435 shares during the period. Finally, ABLE Financial Group LLC increased its holdings in shares of HealthEquity by 14.0% during the 2nd quarter. ABLE Financial Group LLC now owns 25,845 shares of the company’s stock worth $2,708,000 after purchasing an additional 3,174 shares during the period. Institutional investors own 99.55% of the company’s stock.
Analysts Set New Price Targets
Several research firms have recently issued reports on HQY. Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a report on Saturday, September 27th. Barrington Research reiterated an “outperform” rating and set a $125.00 target price on shares of HealthEquity in a research report on Friday, August 29th. Jefferies Financial Group lifted their target price on shares of HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a research report on Wednesday, September 3rd. Royal Bank Of Canada lifted their target price on shares of HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, September 3rd. Finally, JPMorgan Chase & Co. lifted their target price on shares of HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a research report on Wednesday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $119.77.
Insider Activity at HealthEquity
In other news, EVP Michael Henry Fiore sold 1,794 shares of the company’s stock in a transaction that occurred on Monday, July 7th. The shares were sold at an average price of $101.73, for a total value of $182,503.62. Following the completion of the transaction, the executive vice president owned 53,225 shares in the company, valued at $5,414,579.25. This represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Delano Ladd sold 6,000 shares of the company’s stock in a transaction that occurred on Friday, September 19th. The shares were sold at an average price of $94.11, for a total transaction of $564,660.00. Following the completion of the transaction, the executive vice president owned 79,456 shares of the company’s stock, valued at $7,477,604.16. This trade represents a 7.02% decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by corporate insiders.
HealthEquity Stock Down 1.2%
Shares of NASDAQ:HQY opened at $88.59 on Friday. HealthEquity, Inc. has a 52 week low of $74.07 and a 52 week high of $116.65. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23. The company has a market capitalization of $7.63 billion, a PE ratio of 53.69, a PEG ratio of 1.29 and a beta of 0.47. The company has a 50 day moving average price of $92.15 and a two-hundred day moving average price of $93.72.
HealthEquity Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also
- Five stocks we like better than HealthEquity
- Using the MarketBeat Dividend Yield Calculator
- After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught?
- Most Volatile Stocks, What Investors Need to Know
- Alphabet: After Its Best Quarter in Decades, Is It Time to Buy?
- What Are Dividend Challengers?
- Forget Airlines—These Trucking Stocks Are Shifting Into High Gear
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.